• TargetMol
    您的购物车当前为空

Anti-Mosunetuzumab Antibody (9L411)

一键复制产品信息
Rating icon 还可以
货号 TMAS-00055

别名 RO7030816, RO 7187797, RG 7828, RG 6160, Mosunetuzumab-axgb, Lunsumio, Cevostamab, BTCT-4465A, BFCR 4350A, Anti-FCRH5/CD3 BiTE

Anti-Mosunetuzumab Antibody (9L411) 是一种 Rabbit 抗体,靶向 Mosunetuzumab。Anti-Mosunetuzumab Antibody (9L411) 可用于 ELISA, Sandwich ELISA, Competitive ELISA。

Anti-Mosunetuzumab Antibody (9L411)

Anti-Mosunetuzumab Antibody (9L411)

一键复制产品信息
Rating icon 还可以
货号 TMAS-00055 别名 RO7030816, RO 7187797, RG 7828, RG 6160, Mosunetuzumab-axgb, Lunsumio, Cevostamab, BTCT-4465A, BFCR 4350A, Anti-FCRH5/CD3 BiTE

Anti-Mosunetuzumab Antibody (9L411) 是一种 Rabbit 抗体,靶向 Mosunetuzumab。Anti-Mosunetuzumab Antibody (9L411) 可用于 ELISA, Sandwich ELISA, Competitive ELISA。

规格价格库存数量
40 μg
¥ 3,218
5日内发货
库存状态实时更新,以官网显示为准,现货产品可直接加购物车下单
大包装 & 定制
加入购物车
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
实验操作小课堂
常见问题解答
查看更多
资源下载:

产品介绍


生物活性
产品描述
Anti-Mosunetuzumab Antibody (9L411) is a Rabbit antibody targeting Mosunetuzumab. Anti-Mosunetuzumab Antibody (9L411) can be used in ELISA, Sandwich ELISA, Competitive ELISA.
别名RO7030816, RO 7187797, RG 7828, RG 6160, Mosunetuzumab-axgb, Lunsumio, Cevostamab, BTCT-4465A, BFCR 4350A, Anti-FCRH5/CD3 BiTE
Ig Type
IgG, κ
克隆号
9L411
特异性
Mosunetuzumab and Cevostamab
应用ELISASandwich ELISACompetitive ELISA
推荐剂量
ELISA: 0.01-1 µg/ml; Sandwich ELISA: 0.4-2 μg/ml; Competitive ELISA: 1-10 μg/ml
抗体种类
Monoclonal
宿主来源Rabbit
纯化方式Protein A affinity column
性状Lyophilized. Reconstitute the lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/mL.
缓冲液Lyophilized with PBS, pH 7.2, containing 0.02% sodium azide.
研究背景Mosunetuzumab is an innovative bispecific antibody that has a structure that resembles a natural human antibody, with two 'Fab' regions. However, it differs from naturally-occurring antibodies as one 'Fab' region targets CD20 and the other targets CD3. By recognizing and binding to these two different targets, Mosunetuzumab is able to redirect the cytotoxic activity of T-cells towards cancerous B-cells. This unique mechanism of action holds great potential for enhancing the effectiveness of cancer treatment. Cevostamab (BFCR4350A) is an innovative bispecific antibody, designed to engage T-cells and myeloma cells by targeting FcRH5 and CD3 receptors, respectively. Cevostamab possesses a unique structure with two 'Fab' regions, with one specifically targeting FcRH5 and the other targeting CD3. This dual targeting mechanism activates the patient's own T-cells and redirects them to eliminate myeloma cells expressing FcRH5 by releasing cytotoxic proteins.
偶联与修饰
偶联
Unconjugated
抗原信息
免疫原
Mosunetuzumab
储存&溶解度
储存方式The lyophilized product store at -20°C or -80°C for 12 months. The reconstituted antibody can be stored at 2°C-8°C for 2-3 weeks or at -20°C for 12 months. Avoid repeated freeze-thaw cycles.
运输方式Shipping with blue ice.
存储-20°C for 1 year

计算器

  • 稀释 计算器
Related Tags: buy Anti-Mosunetuzumab Antibody (9L411) | purchase Anti-Mosunetuzumab Antibody (9L411) | Anti-Mosunetuzumab Antibody (9L411) cost | order Anti-Mosunetuzumab Antibody (9L411)